Nicole Blackman

1.5k total citations · 2 hit papers
22 papers, 985 citations indexed

About

Nicole Blackman is a scholar working on Hematology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Nicole Blackman has authored 22 papers receiving a total of 985 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 6 papers in Genetics and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Nicole Blackman's work include Erythropoietin and Anemia Treatment (9 papers), Iron Metabolism and Disorders (6 papers) and Platelet Disorders and Treatments (5 papers). Nicole Blackman is often cited by papers focused on Erythropoietin and Anemia Treatment (9 papers), Iron Metabolism and Disorders (6 papers) and Platelet Disorders and Treatments (5 papers). Nicole Blackman collaborates with scholars based in United States, Poland and Canada. Nicole Blackman's co-authors include John J. Koval, Fiona Campbell, Nezam H. Afdhal, Dickens Theodore, Marc Bourlière, J.M. Jenkins, Stuart C. Gordon, John G. McHutchison, Mitchell L. Shiffman and M. Rodríguez‐Torres and has published in prestigious journals such as New England Journal of Medicine, Blood and Gastroenterology.

In The Last Decade

Nicole Blackman

18 papers receiving 956 citations

Hit Papers

Ferric Carboxymaltose in Heart Failure with Iron Deficiency 2023 2026 2024 2025 2023 2023 40 80 120

Peers

Nicole Blackman
Kelly M. Grotzinger United States
Christy Chuang United States
Lucy Rowell United Kingdom
Anna Forsythe United States
Yijie Zhou United States
Nicole Blackman
Citations per year, relative to Nicole Blackman Nicole Blackman (= 1×) peers Sofia Ernestam

Countries citing papers authored by Nicole Blackman

Since Specialization
Citations

This map shows the geographic impact of Nicole Blackman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicole Blackman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicole Blackman more than expected).

Fields of papers citing papers by Nicole Blackman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicole Blackman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicole Blackman. The network helps show where Nicole Blackman may publish in the future.

Co-authorship network of co-authors of Nicole Blackman

This figure shows the co-authorship network connecting the top 25 collaborators of Nicole Blackman. A scholar is included among the top collaborators of Nicole Blackman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicole Blackman. Nicole Blackman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ezekowitz, Justin A., Hillary Mulder, Robert J. Mentz, et al.. (2025). Prediction and Longer-Term Outcomes of All-cause and Cardiovascular Mortality in the HEART-FID Trial. Journal of Cardiac Failure. 31(12). 1822–1833.
2.
Lewis, Gregory D., Anna Giczewska, Robert J. Mentz, et al.. (2025). Functional and Prognostic Implications of Different Iron Deficiency Definitions in Heart Failure. JACC Heart Failure. 13(12). 102661–102661.
4.
Harrington, Josephine, Robert J. Mentz, Frank W. Rockhold, et al.. (2024). Hierarchical End Points in Prior Heart Failure Trials and the HEART-FID Trial. Circulation Heart Failure. 17(2). e010676–e010676.
5.
Korczowski, Bartosz, et al.. (2023). Safety, pharmacokinetics, and pharmacodynamics of intravenous ferric carboxymaltose in children with iron deficiency anemia. Pediatric Research. 94(4). 1547–1554. 5 indexed citations
6.
Mentz, Robert J., Jyotsna Garg, Frank W. Rockhold, et al.. (2023). Ferric Carboxymaltose in Heart Failure with Iron Deficiency. New England Journal of Medicine. 389(11). 975–986. 120 indexed citations breakdown →
7.
Ponikowski, Piotr, Robert J. Mentz, Adrian F. Hernandez, et al.. (2023). Efficacy of ferric carboxymaltose in heart failure with iron deficiency: an individual patient data meta-analysis. European Heart Journal. 44(48). 5077–5091. 67 indexed citations breakdown →
8.
Harrington, Josephine, Robert J. Mentz, Frank W. Rockhold, et al.. (2023). Baseline characteristics of patients in the randomized study to investigate the efficacy and safety of ferric carboxymaltose as treatment for heart failure with iron deficiency: HEART-FID trial. American Heart Journal. 266. 25–31. 2 indexed citations
9.
Jones, John J., et al.. (2021). Ferric Carboxymaltose for Anemic Perioperative Populations: A Systematic Literature Review of Randomized Controlled Trials. Journal of Blood Medicine. Volume 12. 337–359. 8 indexed citations
10.
Makharadze, Tamta, Ralph V. Boccia, Anna Julia Krupa, et al.. (2021). Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, placebo‐controlled study (IRONCLAD). American Journal of Hematology. 96(12). 1639–1646. 15 indexed citations
11.
Stasyshyn, Oleksandra, Claudia Djambas Khayat, Genadi Iosava, et al.. (2017). Safety, efficacy and pharmacokinetics of rVIII‐SingleChain in children with severe hemophilia A: results of a multicenter clinical trial. Journal of Thrombosis and Haemostasis. 15(4). 636–644. 30 indexed citations
12.
Ledger, Katie St., Annette Feussner, Uwe Kalina, et al.. (2017). International comparative field study evaluating the assay performance of AFSTYLA in plasma samples at clinical hemostasis laboratories. Journal of Thrombosis and Haemostasis. 16(3). 555–564. 29 indexed citations
13.
Santagostino, Elena, U. Martinowitz, Toshko Lissitchkov, et al.. (2016). Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial. Blood. 127(14). 1761–1769. 150 indexed citations
14.
Klamroth, Robert, Mindy Simpson, Joan Cox Gill, et al.. (2016). Comparative pharmacokinetics of rVIII‐SingleChain and octocog alfa (Advate®) in patients with severe haemophilia A. Haemophilia. 22(5). 730–738. 42 indexed citations
15.
Afdhal, Nezam H., Edoardo G. Giannini, Angelo Andriulli, et al.. (2010). 1185 ELTROMBOPAG IN CHRONIC LIVER DISEASE PATIENTS WITH THROMBOCYTOPENIA UNDERGOING AN ELECTIVE INVASIVE PROCEDURE: RESULTS FROM ELEVATE, A RANDOMISED CLINICAL TRIAL. Journal of Hepatology. 52. S460–S460. 10 indexed citations
16.
Afdhal, Nezam H., John G. McHutchison, Fiona Campbell, et al.. (2008). W1019 Effects of Eltrombopag On Thrombopietin Levels During Antiviral Therapy in HCV Patients with Cirrhosis. Gastroenterology. 134(4). A–833.
17.
McHutchison, John G., Geoffrey Dusheiko, Mitchell L. Shiffman, et al.. (2007). Eltrombopag for Thrombocytopenia in Patients with Cirrhosis Associated with Hepatitis C. New England Journal of Medicine. 357(22). 2227–2236. 327 indexed citations
18.
Logie, John, et al.. (2004). 1548: Racial Differences in the Risk of Benign Prostatic Hyperplasia (BPH) Progression and Prostate Cancer. The Journal of Urology. 171(4S). 408–408. 1 indexed citations
19.
Blackman, Nicole. (2004). Reproducibility of clinical data II: categorical outcomes. Pharmaceutical Statistics. 3(2). 109–122. 2 indexed citations
20.
Blackman, Nicole & John J. Koval. (2000). Interval estimation for Cohen's kappa as a measure of agreement. Statistics in Medicine. 19(5). 723–741. 164 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026